植入人间介质干细胞颗粒用于治疗性血管生成

Akiko Mammoto1, Priscilla Kyi2, Mikaela Scheer2

  • 1Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA; Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Cytotherapy
|December 20, 2025
PubMed
概括

这项研究开发了一种可植入的人类介质干细胞 (MSC) 颗粒,可以稳定地在小鼠中植入,从而使MSC适应性和增强血管生成的治疗潜力的临床前分析成为可能.